COMESA Warns Of Fake Breast Cancer Drug Reported In Kenya » Capital News

NAIROBI, Kenya, May 15 – The COMESA Competition Commission has warned its member states against the sale of a false batch of cancer medicine identified as Herceptin 440 mg (Trastuzumab 440mg) reported to have penetrated the Kenyan market. This comes…